LEPU BIOPHARMA CO LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 2157 for the last semiannual is 77.57 M HKD, and it's 55.33% lower compared to the previous semiannual. The net income of H2 23 is 129.43 M HKD.